tiprankstipranks
Blurbs

Analysts’ Top Healthcare Picks: United Therapeutics (UTHR), Zentalis Pharmaceuticals (ZNTL)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on United Therapeutics (UTHRResearch Report) and Zentalis Pharmaceuticals (ZNTLResearch Report) with bullish sentiments.

United Therapeutics (UTHR)

In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on United Therapeutics, with a price target of $236.00. The company’s shares closed last Friday at $168.00.

According to TipRanks.com, Moussatos ‘ ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -5.8% and a 31.9% success rate. Moussatos covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, BioMarin Pharmaceutical, and Pacira Pharmaceuticals.

Currently, the analyst consensus on United Therapeutics is a Strong Buy with an average price target of $235.80, implying a 41.8% upside from current levels. In a report issued on February 25, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $203.00 price target.

See the top stocks recommended by analysts >>

Zentalis Pharmaceuticals (ZNTL)

In a report issued on February 24, Andrew Berens from Leerink Partners maintained a Buy rating on Zentalis Pharmaceuticals, with a price target of $78.00. The company’s shares closed last Friday at $51.32.

According to TipRanks.com, Berens is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -9.0% and a 41.5% success rate. Berens covers the Healthcare sector, focusing on stocks such as Forma Therapeutics Holdings, Turning Point Therapeutics, and Deciphera Pharmaceuticals.

Currently, the analyst consensus on Zentalis Pharmaceuticals is a Strong Buy with an average price target of $98.00, a 90.8% upside from current levels. In a report issued on February 25, H.C. Wainwright also reiterated a Buy rating on the stock with a $120.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on UTHR:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More